Identification of a new way to induce differentiation of dermal fibroblasts into vascular endothelial cells

Stem Cell Res Ther. 2022 Oct 9;13(1):501. doi: 10.1186/s13287-022-03185-4.

Abstract

Background: Human dermal fibroblasts (HDFs) have the potential to differentiate into vascular endothelial cells (VECs), but their differentiation rate is low and the mechanism involved is not clear. The small molecule pathway controls the phenotype of fibroblasts by activating cellular signaling pathways, which is a more convenient method in the differentiation strategy of HDFs into VECs.

Methods: In this study, HDFs were treated with the different doses of CPP ((E)-4-(4-(4-(7-(diethylamino)-2-oxo-2H-chromene-3-carbonyl) piperazin-1-yl) styryl)-1-methylpyridin-1-ium iodide), and the mRNA and protein levels of HDFs were detected by qPCR, Western blot, flow cytometry and immunofluorescent staining. The matrigel assays, acetylated-LDL uptake and angiogenesis assays of chick embryo chorioallantoic membrane (CAM) and hindlimb ischemia model of nude mice were performed to evaluate the functions of VECs derived from HDFs.

Results: Here, we report that the small chemical molecule, CPP, can effectively induce HDFs to differentiate into VECs. First, we observed the morphological changes of HDFS treated with CPP. Flow cytometry, Western blot and qRT-PCR analyses showed that CPP effectively decreased the level of the HDFs-marker Vimentin and increased levels of the VEC-markers CD31, CD133, TEK, ERG, vWF, KDR and CDH5. Detection of the percentage of CD31-positive cells by immunofluorescent staining confirmed that CPP can effectively induce HDFs to differentiate into VECs. The results of Matrigel assays, DiI-ac-LDL uptake, angiogenesis assays on CAM and hindlimb ischemia model of nude mice showed that CPP-induced HDFs have the functions of VECs in vitro and in vivo. Western blot and qRT-PCR analysis showed that CPP induces HDFs to differentiate into VECs by promoting the expression of pro-angiogenic factors (VEGF, FGF-2 and PDGF-BB).

Conclusions: Our data suggest that the small chemical molecule CPP efficiently induces the differentiation of HDFs into VECs. Simultaneously, this new inducer provides a potential to develop new approaches to restore vascular function for the treatment of ischemic vascular diseases.

Keywords: Differentiation; Human dermal fibroblasts; Small chemical molecule; Vascular endothelial cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Becaplermin / metabolism
  • Cells, Cultured
  • Chick Embryo
  • Endothelial Cells* / metabolism
  • Fibroblast Growth Factor 2 / metabolism
  • Fibroblasts / metabolism
  • Humans
  • Iodides / metabolism
  • Ischemia / therapy
  • Mice
  • Mice, Nude
  • Neovascularization, Pathologic / metabolism
  • RNA, Messenger / metabolism
  • Vascular Endothelial Growth Factor A* / metabolism
  • Vimentin / metabolism
  • von Willebrand Factor / metabolism

Substances

  • Iodides
  • RNA, Messenger
  • Vascular Endothelial Growth Factor A
  • Vimentin
  • von Willebrand Factor
  • Fibroblast Growth Factor 2
  • Becaplermin